Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Heron Therapeutics, Inc. (HRTX) had Weighted-Average Shares Outstanding (Diluted) of 170.35M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$38.21M |
|
$-17.50M |
|
$11.91M |
|
$26.30M |
|
$42.31M |
|
$-4.09M |
|
$-13.40M |
|
$-17.50M |
|
$-17.50M |
|
$-17.50M |
|
$-17.50M |
|
$-17.50M |
|
$-17.50M |
|
$-4.09M |
|
$-3.93M |
|
170.35M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
170.35M |
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$229.40M |
|
$12.96M |
|
$19.55M |
|
$248.95M |
|
$89.71M |
|
$139.66M |
|
$144.36M |
|
$234.06M |
|
$7.02M |
|
$14.88M |
|
$14.88M |
|
183.32M |
|
| Cash Flow Statement Financials | |
$-18.41M |
|
$21.46M |
|
$14.21M |
|
$25.80M |
|
$43.07M |
|
$17.27M |
|
$8.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.56 |
|
-- |
|
-- |
|
0.90 |
|
9.38 |
|
68.82% |
|
-10.71% |
|
-10.71% |
|
-- |
|
-45.78% |
|
-45.78% |
|
$-18.64M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.17 |
|
0.47 |
|
190.88 |
|
-249.11% |
|
-117.53% |
|
-7.03% |
|
-11.32% |
|
$0.08 |
|
$-0.11 |
|
$-0.11 |
|